Journal of Clinical ImmunologyGenetic & Genomic MedicinePeer-reviewed journal article
A germline heterozygous dominant negative IKZF2 variant causing syndromic primary immune regulatory disorder and ICHAD
Henry Y. LuiD, Maryam Vaseghi‐ShanjaniiD, Avery J. LamiD, Mehul SharmaiD, Arezoo MohajeriiD, Leandro Buffoni Roque da SilvaiD, Jana K. Gillies, Gui Xiang Yang, Susan Xiaoqin LiniD, Maggie P. FuiD, Areesha SalmaniD, Ronak RahmanianiD, Linlea ArmstrongiD, Jessica Halparin, Connie L. YangiD, Mark A. ChilversiD, Erika HenkelmaniD, Wingfield RehmusiD, Douglas C. Morrison, Audi SetiadiiD, Sara MostafaviiD, Michael Steffen KoboriD, Frederick K. KozakiD, Catherine M. BiggsiD, Clara van KarnebeekiD, , Stuart E. TurveyiD
Abstract
Monogenic defects that impair the control of inflammation and tolerance lead to profound immune dysregulation, including autoimmunity and atopy. Studying these disorders reveals important molecular and cellular factors that regulate human immune homeostasis and identifies potential precision medicine targets. Here, we provide a detailed immunological assessment of a pediatric patient with a recently discovered syndrome causing Immunodysregulation, Craniofacial anomalies, Hearing impairment, Athelia, and Developmental delay (or ICHAD syndrome). The immunodysregulation resulted in autoimmune hemolytic anemia (AIHA) and atopic dermatitis. The patient carried a de novo germline heterozygous c.406+540_574+13477dup;p.Gly136_Ser191dup variant in IKAROS family zinc finger 2 (IKZF2), which encodes Helios. This variant led to reduced Helios protein expression and dominant interference of wild-type Helios-mediated repression of the IL2 promoter. Multi-parameter flow cytometric analyses of patient peripheral blood mononuclear cells revealed strongly impaired natural killer cell differentiation and function, and increased CD8+ T cell activation and cytokine secretion. Strikingly, patient CD4+ T cells were hyperactive, produced elevated levels of nearly all T helper (TH) cytokines, and readily proliferated in response to stimulation. Patient regulatory T cells (Tregs) developed normally but aberrantly produced high levels of many TH cytokines. Single-cell RNA sequencing revealed largely normal Tregs (albeit mostly memory), but naive CD4+ T cells that were more enriched in genes related to activation, proliferation, metabolism, and TH differentiation. This work describes the immunological phenotype of one of the first reported cases of germline dominant negative Helios deficiency, expands our understanding of the pathogenesis of AIHA on a single cell level, and provides valuable insights into Helios function in a variety of lymphocyte subsets.
- organism: human
- assay: bulk RNA-seq
- assay: proteomics
- research focus: differential expression
- research focus: cell type annotation
- approach: statistical model
- Citations
- 6
- FWCI
- 2.21
- Field percentile
- top 13%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genetic immunodeficiency and autoimmune disease reveal distinct roles of Hem1 in the WAVE2 and mTORC2 complexes
W. A. Comrie, M. C. Poli, … M. J. Lenardo·bioRxiv·Jul 4, 2019
- Characterization of a mouse model of ICF syndrome reveals enhanced CD19 activation in inducing hypogammaglobulinemia
Z. Ying, S. Hardikar, … T. Chen·bioRxiv·Mar 9, 2023
- A PATHOGENIC NFKB2 VARIANT CAUSES COMBINED IMMUNODEFICIENCY WITH THYMIC AND PERIPHERAL LYMPHOID DEFECTS IN RATS
Séverine Remy, Laurent Tesson, … Ignacio Anegón·bioRxiv·Oct 8, 2026
- IRAK2 deficiency causes a new immune dysregulation disorder
Yudie Fei, Lin Liu, … Zhihong Liu·medRxiv·Oct 21, 2024
- Autosomal dominant CDC45 deficiency with allelic expression bias causes a novel genetic disease of the immune system
Nicole C. Guilz, Yong‐Oon Ahn, … Emily Margaret Mace·bioRxiv·Mar 6, 2026
- A minimal two-residue C-terminal truncation of AID in adult-onset hyper-IgM syndrome type 2 (HIGM2)
K. Green, A. B. Rovsing, … S. E. Degn·bioRxiv·Nov 2, 2026